New treatment for opioid-induced constipation / Diane S. Aschenbrenner
Series: American Journal of Nursing. 115 : 1, page 23 Publication details: January 2015ISSN:- 0002-936X
Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|
Manila Tytana Colleges Library REFERENCE SECTION | Bound (Browse shelf(Opens below)) | Not For Loan |
An opioid antagonist, naloxegol (Movantik), has now been approved to treat opioid-induced constipation in adults with chronic noncancer pain. Naloxegol binds to mu-opiate receptors in the gastrointestinal tract, preventing opioids from attaching to them, which prevents the gastrointestinal slowing and constipation that typically occur with opioid use.
Nursing
There are no comments on this title.